Mission Therapeutics was granted $500,000 from the The Michael J Fox Foundation for Parkinson’s Research for DUB inhibitor testing.
List view / Grid view
Michael J. Fox Foundation for Parkinson's Research (MJFF)
25 May 2016 | By Victoria White, Digital Content Producer
MJFF is to fund two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease...
3 May 2016 | By Victoria White, Digital Content Producer
Oral administration of a Jakinib lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's...
The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson’s disease
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...